Patents and Applications. All right, title and interest in all patents and patent applications owned by, acquired by, issued to, naming, filed by or on behalf of, Seller or Xxxxxxxx, or in which Seller or Xxxxxxxx have a legal or equitable right of ownership, through the Closing Date, disclosing or claiming any invention, modification, or advance referred to in Section (a); any further applications claiming a right of priority from such patents or patent applications (including, without limitation, any divisional, continuation, continuation-in-part, or convention applications); and any patents issuing on any such applications; any reissue, reexamination or extension of any such patents; such patents and applications including, by way of non-limiting example, United States Patent Application Serial No. 08/409,317, filed on 3/23/95, entitled "System Permitting the External Replacement of the CPU and/or DRAM XXXXx Microchip Board" (the "Patent Application") and the "additional" patent application (not yet filed) referred to in the letter dated December 19, 1996, from Hamirani's counsel to Xx. Xxxxxx X. Kransdorf (the "Additional Patent Application");
Patents and Applications. (i) Issued
i. Industry-Wide Business to Business Exchange; patent number 7987116; issued July 26, 2011; invented by Xxxxx Xxxxxxx, Xxxx Xxxx, and Xxxx XxXxxxxx; firm reference number, XxXxxxxxx, Will & Xxxxx; serial number, 09/968,621.
(ii) Filed and Published
i. Two Factor Authentication Scheme (IDCipher); serial number 12/713,246; filed February 26, 2010, invented by Xxxxx Xxxxxx; firm reference number, Harness Xxxxxx (15245-000002/US).
ii. Industry-Wide Business to Business Exchange; serial number 13/179,908; filed July 11, 2011, invented by Xxxxx Xxxxxxx, Xxxx Penn, and Xxxx XxXxxxxx; firm reference number, Harness Xxxxxx 15245-000006/US/COA; continuation of 09/968,621, Patent # 7,987,116 (XxXxxxxxx) detailed above.
Patents and Applications. [***] 2 The parties hereby agree that Sigilon has no additional rights under Section 2.2. Except as specifically modified or amended hereby, all other terms and conditions of the License Agreement shall remain unchanged and in full force and effect.
Patents and Applications. Schedule 1 contains a correct, current, and complete list of all patents and patent applications related to the Licenses, including the Acquired Patents and the Merck Serono Patents (as defined in the Merck Serono License), specifying as to each, as applicable, the title, the record owner, the jurisdiction in which it has been issued or filed, the patent number or application serial or publication number, and the issue or application filing date. All required filings and fees related to the Acquired Patents listed on Schedule 1 have been timely filed with and paid to the USPTO and other relevant governmental authorities and authorized registrars, and all such patents and patent applications have at all times been and remain in good standing. Seller has provided Buyer with true and complete copies of all documents, certificates, office actions, responses, correspondence, and other filings and materials related to all such Acquired Patents. Seller has satisfied, and will continue to satisfy, all of its obligations to the inventors of the Acquired Patents (if any).
Patents and Applications. WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS
Patents and Applications. 11.2 (d)(1)(2) Consents
Patents and Applications. PCT Patent Application Serial No. PCT/US99/00088, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays” designating Australia, Canada, all member countries of the EPC, Japan, Republic of Korea EPC Patent Application Serial No. 99901294.1, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays”, designating all member countries of the EPC JP Patent Application Serial No. 2000-527355, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays”. CAN Patent Application Serial No. 2316912, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays”. For all of the following jurisdictions for which PATENT RIGHTS applications are still valid as of the EFFECTIVE DATE: Canada, France, Germany, Ireland, Italy, Japan, Republic of Korea, Spain, Sweden, Switzerland and the United Kingdom. Five Cambridge Center, Xxxxxxx Square, Room NE25-230 Xxxxxxxxx, Xxxxxxxxxxxxx 00000-0000 Phone 000-000-0000 Fax 000-000-0000 Email xxx@xxx.xxx xxxx://xxx.xxx.xxx/tlo/ December 21, 2004. Dear Xxxx: Our recent discussions indicate that BioTrove is making progress toward first commercial sale of product but may not be able to meet the impending deadline of December 31, 2004. In addition, we have come to the conclusion that it is not necessary to have Errors & Omissions Insurance coverage until this sale takes place. Therefore, M.I.T. is offering to amend Section 8.2, subsection (iii) of the above referenced license agreement to read as follows: “...shall be endorsed to include product liability coverage and errors and omissions coverage prior to the first commercial sale of a LICENSED PRODUCT...” (emphasis added for convenience).
Patents and Applications. Patent No. Application No. Publication No. Title Filing Date (MM/DD/YYYY) Status Foreign Patents and Applications Application/ Publication No. Patent No. Title Publication Date (MM/DD/YYYY) Status
Patents and Applications. (a) Following the execution of this Agreement, the Licensor shall furnish to the Licensee at its request, or to its nominees and patent attorneys, all information and documents regarding the Technology, including a description of the processes which the Technology incorporates, in order to enable the Licensee to operate hereunder.
(b) The Licensor covenants and warrants that a patent application was filed with the United States Patent Office as specified hereinabove. The Licensor agrees to assume responsibility for all further prosecution of the Patent Application and any subsequent patent applications, provided the Licensee pays all of the costs thereof, including but not limited to, attorneys', engineering and drafting fees and all other costs of a similar nature, that accrue after the date of this Agreement.
(c) The Licensor further covenants and warrants that a PCT application was timely filed with the United States Patent Office. The Licensor grants to the Licensee the right to file for patent protection for the Technology, in the name of the Licensor, in all other countries of the world, at the Licensee's sole cost and expense.
(d) The Licensor shall deliver to the Licensee, immediately upon execution of this Agreement, all research and development reports and studies that have been completed or compiled as of the date hereof, and all other data relating to the Technology, and shall execute all papers, documents and instruments necessary to enable the Licensee to cause to be prepared, filed and prosecuted, at the Licensee's expense, applications for letters patent within such countries of the world as the Licensee shall, in its sole discretion, determine is advisable.
(e) The Licensee shall mark all Licensed Products maxxxxctured and distributed under this Agreement with patent numbers in accordance with statutory requirements and, pending the issue of any patents, shall stamp the Licensed Products "Patent Applied For".
(f) All patents granted with respect to the Technology or any improvements thereof shall be the exclusive property of the Licensor, subject to the license hereby granted. For purposes of this Agreement, "improvement," shall include any method, process, technology, device or products within the scope of the Technology that improves the performance, reliability, effectiveness, ease of use , marketability, and/or maintenance of the Licensed Products and their components. The Licensor shall, upon demand, execute and deliver to the License...
Patents and Applications. WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS WG&S ID SN FILING DATE INVENTORS ASSIGNEES TITLE STATUS
